eXoZymes, Inc. (EXOZ)
6.25
-0.18
(-2.87%)
USD |
NASDAQ |
Sep 21, 16:00
6.25
0.00 (0.00%)
After-Hours: 20:00
eXoZymes Total Assets (Quarterly) : 7.982M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.982M |
| March 31, 2026 | 4.019M |
| December 31, 2025 | 5.972M |
| September 30, 2025 | 7.719M |
| June 30, 2025 | 9.677M |
| March 31, 2025 | 11.53M |
| Date | Value |
|---|---|
| December 31, 2024 | 13.03M |
| September 30, 2024 | 3.560M |
| June 30, 2024 | |
| December 31, 2023 | 3.558M |
| December 31, 2022 | 2.686M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 183.47M |
| Perspective Therapeutics, Inc. | 392.02M |
| MiMedx Group, Inc. | 281.00M |
| ABVC BioPharma, Inc. | 19.40M |
| bioAffinity Technologies, Inc. | 7.619M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.328M |
| Shareholders Equity (Quarterly) | 3.654M |
| Debt to Equity Ratio | 0.2969 |
| Current Ratio | 3.813 |
| Net Debt Paydown Yield | 0.06% |